Bellwave-003: A Phase 2 Study to Evaluate the Efficacy and Safety of MK-1026 in Participants With Hematologic Malignancies

Condition: CLL/SLL, Marginal Zone Lymphoma, Richter's transformation


Go To Trial Homepage